Free Trial

Scilex (SCLXW) 10K Form and Latest SEC Filings 2026

Scilex logo
$0.13 -0.01 (-10.00%)
Closing price 05/22/2026 03:35 PM Eastern
Extended Trading
$0.14 +0.01 (+8.73%)
As of 05/22/2026 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Scilex SEC Filings & Recent Activity

Scilex (NASDAQ:SCLXW) has submitted 522+ documents to the U.S. Securities and Exchange Commission (SEC) since 2020. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form EFFECT submitted on May 25, 2026.

Form 4
Scilex Holding Co Reports Ownership Change on Apr. 20, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Scilex Files Current Report on May. 11, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Scilex Files Quarterly Report on May. 20, 2026

The 10-Q contains Scilex's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Scilex SEC Filing History

Browse Scilex's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/25/2026 11:15 PM
Scilex (1820190) Filer
Form EFFECT
05/20/2026 4:22 PM
Scilex (1820190) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2026 3:32 PM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2026 3:05 PM
Scilex (1820190) Filer
Form DEFA14A
05/05/2026 12:24 PM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2026 3:58 PM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2026 7:52 AM
Ji Henry (1470981) Reporting
Scilex (1820190) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/20/2026 7:56 AM
Ma Stephen Hoi (1954364) Reporting
Scilex (1820190) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2026 4:11 PM
Scilex (1820190) Filer
Form S-3
Registration statement under Securities Act of 1933  
04/10/2026 4:29 PM
Scilex (1820190) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/01/2026 5:03 AM
Scilex (1820190) Filer
Form NT 10-K
03/13/2026 11:59 AM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2026 5:03 AM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2026 7:07 PM
Scilex (1820190) Filer
Form 424B3
02/20/2026 7:09 PM
Scilex (1820190) Filer
Form 424B3
02/20/2026 7:11 PM
Scilex (1820190) Filer
Form 424B3
02/20/2026 3:14 PM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2026 3:10 PM
ORAMED PHARMACEUTICALS INC. (1176309) Filed by
Scilex (1820190) Subject
Form SCHEDULE 13G/A
02/03/2026 4:03 PM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2026 3:07 PM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2026 7:16 PM
Datavault AI Inc. (1682149) Subject
Scilex (1820190) Filed by
Form SCHEDULE 13D/A
01/14/2026 7:04 PM
Datavault AI Inc. (1682149) Issuer
Scilex (1820190) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2026 6:49 PM
Datavault AI Inc. (1682149) Subject
Scilex (1820190) Filed by
Form SCHEDULE 13D/A
01/08/2026 5:44 PM
Datavault AI Inc. (1682149) Issuer
Scilex (1820190) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2026 5:02 AM
Scilex (1820190) Filer
Form RW
12/31/2025 7:50 AM
Datavault AI Inc. (1682149) Issuer
Scilex (1820190) Reporting
Form 4/A
12/31/2025 7:54 AM
Datavault AI Inc. (1682149) Subject
Scilex (1820190) Filed by
Form SCHEDULE 13D/A
12/30/2025 7:24 PM
Scilex (1820190) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2025 2:37 PM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2025 11:15 PM
Scilex (1820190) Filer
Form EFFECT
12/29/2025 3:31 PM
Scilex (1820190) Filer
Form 424B3
12/22/2025 2:55 PM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2025 9:42 AM
Scilex (1820190) Filer
Form 424B3
12/17/2025 9:43 AM
Scilex (1820190) Filer
Form 424B3
12/17/2025 9:44 AM
Scilex (1820190) Filer
Form 424B3
12/17/2025 9:28 AM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2025 8:39 PM
Scilex (1820190) Filer
Form S-1
Registration statement under Securities Act of 1933  
12/12/2025 3:40 PM
Scilex (1820190) Filer
Form 424B3
12/12/2025 3:43 PM
Scilex (1820190) Filer
Form 424B3
12/12/2025 3:45 PM
Scilex (1820190) Filer
Form 424B3
12/12/2025 3:16 PM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The SpaceX filing is public. The window is closing. (Ad)

SpaceX just filed its S-1. The IPO is confirmed for June 12 - $75 billion, ticker SPCX, potentially the largest in history. The 21-bank syndicate has already locked up shares, so retail investors won't get access. But the S-1 exposed one publicly traded company Musk cannot operate without - and it's still cheap. Dylan Jovine is releasing the ticker free before June 12 changes the price.tc pixel

Get the ticker before the SpaceX IPO reprices everything on June 12
12/11/2025 4:27 PM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2025 4:27 PM
Scilex (1820190) Filer
Form 424B3
12/11/2025 4:30 PM
Scilex (1820190) Filer
Form 424B3
12/11/2025 4:30 PM
Scilex (1820190) Filer
Form 424B3
12/05/2025 3:38 PM
Scilex (1820190) Filer
Form 424B3
12/05/2025 3:42 PM
Scilex (1820190) Filer
Form 424B3
12/05/2025 3:45 PM
Scilex (1820190) Filer
Form 424B3
12/01/2025 5:30 AM
Datavault AI Inc. (1682149) Subject
Scilex (1820190) Filed by
Form SCHEDULE 13D
12/01/2025 5:15 AM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2025 5:20 AM
Scilex (1820190) Filer
Form 424B3
12/01/2025 5:21 AM
Scilex (1820190) Filer
Form 424B3
12/01/2025 5:23 AM
Scilex (1820190) Filer
Form 424B3
11/28/2025 8:41 PM
Datavault AI Inc. (1682149) Issuer
Scilex (1820190) Reporting
Form 3
Initial statement of beneficial ownership of securities  
11/28/2025 8:44 PM
Datavault AI Inc. (1682149) Issuer
Scilex (1820190) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2025 4:26 PM
Scilex (1820190) Filer
Form 424B3
11/24/2025 4:15 PM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2025 4:23 PM
Scilex (1820190) Filer
Form 424B3
11/24/2025 4:25 PM
Scilex (1820190) Filer
Form 424B3
11/14/2025 4:19 PM
Scilex (1820190) Filer
Form 424B3
11/14/2025 4:21 PM
Scilex (1820190) Filer
Form 424B3
11/14/2025 4:24 PM
Scilex (1820190) Filer
Form 424B3
11/04/2025 1:21 PM
Scilex (1820190) Filer
Form 424B3
11/04/2025 1:22 PM
Scilex (1820190) Filer
Form 424B3
11/04/2025 1:23 PM
Scilex (1820190) Filer
Form 424B3
11/04/2025 12:21 PM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2025 8:12 AM
Scilex (1820190) Filer
Form 424B3
10/31/2025 8:13 AM
Scilex (1820190) Filer
Form 424B3
10/31/2025 8:16 AM
Scilex (1820190) Filer
Form 424B3
10/31/2025 7:56 AM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2025 4:22 PM
Scilex (1820190) Filer
Form PRE 14A
10/14/2025 3:01 PM
Scilex (1820190) Filed by
Semnur Pharmaceuticals, Inc. (1913577) Subject
Semnur Pharmaceuticals, Inc. (1913577) Subject
Semnur Pharmaceuticals, Inc. (1913577) Subject
Form SCHEDULE 13D/A
10/14/2025 3:01 PM
Scilex (1820190) Filer
Form D
Notice of Exempt Offering of Securities 
10/09/2025 7:47 AM
Scilex (1820190) Issuer
Wu Yue Alexander (1682419) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2025 7:40 AM
Followwill Dorman (1717947) Reporting
Scilex (1820190) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2025 7:42 AM
Ji Henry (1470981) Reporting
Scilex (1820190) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2025 7:43 AM
Chun Jay (1994406) Reporting
Scilex (1820190) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2025 7:45 AM
Ma Stephen Hoi (1954364) Reporting
Scilex (1820190) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2025 3:28 PM
Scilex (1820190) Filer
Form 424B3
10/07/2025 3:24 PM
Scilex (1820190) Filer
Form 424B3
10/07/2025 3:26 PM
Scilex (1820190) Filer
Form 424B3
10/07/2025 3:05 PM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2025 4:14 PM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2025 8:39 PM
Scilex (1820190) Filer
Form 424B3
09/26/2025 8:41 PM
Scilex (1820190) Filer
Form 424B3
09/26/2025 8:43 PM
Scilex (1820190) Filer
Form 424B3
09/26/2025 3:10 PM
Scilex (1820190) Filed by
Semnur, Inc. (1584541) Subject
Form SCHEDULE 13D
09/26/2025 3:10 PM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2025 3:02 PM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2025 3:05 PM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2025 6:49 PM
Scilex (1820190) Reporting
Scilex, Inc. (2084647) Reporting
Semnur Pharmaceuticals, Inc. (1913577) Issuer
Semnur Pharmaceuticals, Inc. (1913577) Issuer
Semnur Pharmaceuticals, Inc. (1913577) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
June 12: $100 Turns Into $100,000? (Ad)

The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before major runs - says the window to get in early is closing fast. Brown is showing investors how to claim a stake in Elon Musk's company before it hits the public markets. Once the IPO happens, this pre-public opportunity disappears.tc pixel

Click here to see how to get ahead of the SpaceX IPO
09/23/2025 6:48 PM
Denali Capital Acquisition Corp. (1913577) Issuer
Denali Capital Acquisition Corp. (1913577) Issuer
Denali Capital Acquisition Corp. (1913577) Issuer
Scilex (1820190) Reporting
Scilex, Inc. (2084647) Reporting
Form 3
Initial statement of beneficial ownership of securities  
08/21/2025 6:12 AM
Scilex (1820190) Filer
Form 424B3
08/21/2025 6:15 AM
Scilex (1820190) Filer
Form 424B3
08/21/2025 6:00 AM
Scilex (1820190) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2025 6:09 AM
Scilex (1820190) Filer
Form 424B3
08/14/2025 5:56 PM
ORAMED PHARMACEUTICALS INC. (1176309) Filed by
Scilex (1820190) Subject
Form SCHEDULE 13G/A
07/23/2025 8:01 AM
Scilex (1820190) Filer
Form 424B3
07/23/2025 8:03 AM
Scilex (1820190) Filer
Form 424B3
07/23/2025 8:06 AM
Scilex (1820190) Filer
Form 424B3
(Data available from 1/1/2016 forward)

Scilex SEC Filings - Frequently Asked Questions

Scilex (SCLXW) has submitted 522+ filings to the SEC since 2020. You can browse the complete history or filter by form type using the tools above.

The most recent filing was a Form EFFECT submitted on May 25, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:SCLXW) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners